Northeast Pharmaceutical Group Co., Ltd. (SHE:000597)
5.25
-0.10 (-1.87%)
Jun 18, 2025, 2:45 PM CST
SHE:000597 Revenue
Northeast Pharmaceutical Group had revenue of 1.95B CNY in the quarter ending March 31, 2025, with 0.36% growth. This brings the company's revenue in the last twelve months to 7.51B, down -4.08% year-over-year. In the year 2024, Northeast Pharmaceutical Group had annual revenue of 7.50B, down -8.98%.
Revenue (ttm)
7.51B
Revenue Growth
-4.08%
P/S Ratio
1.02
Revenue / Employee
1.26M
Employees
5,964
Market Cap
7.63B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 7.50B | -740.62M | -8.98% |
Dec 31, 2023 | 8.24B | -565.77M | -6.42% |
Jan 1, 2023 | 8.81B | 663.83M | 8.15% |
Dec 31, 2021 | 8.15B | 760.76M | 10.30% |
Dec 31, 2020 | 7.38B | -835.75M | -10.17% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Jiangsu Hengrui Medicine | 29.19B |
Shenzhen Mindray Bio-Medical Electronics | 35.59B |
WuXi AppTec | 39.59B |
Sichuan Biokin Pharmaceutical | 5.82B |
Zhangzhou Pientzehuang Pharmaceutical., | 10.76B |
Aier Eye Hospital Group | 21.81B |
Shanghai United Imaging Healthcare | 10.43B |
Yunnan Baiyao Group Co.,Ltd | 40.10B |